GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 07/10/2011
PIL Avodart 0.5mg soft capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to side-effects
Updated on 19/09/2011 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to appearance of the medicine
  • Change to date of revision
Updated on 19/03/2010 and displayed until 19/09/2011
Reasons for adding or updating:
  • Change of manufacturer
  • Change to drug interactions
Updated on 20/08/2008 and displayed until 19/03/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 29/05/2008 and displayed until 20/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 25/01/2006 and displayed until 29/05/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/02/2003 and displayed until 25/01/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   dutasteride